Zobrazeno 1 - 10
of 365
pro vyhledávání: '"Thanyawee P"'
Autor:
Wipaporn Natalie Songtaweesin, Paul Thisayakorn, Renata Arrington‐Sanders, Caroline Foster, Thanyawee Puthanakit
Publikováno v:
Journal of the International AIDS Society, Vol 27, Iss 10, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/67fbd1731e284c82965e39b252566bdf
Autor:
Thanyawee Puthanakit, Eakachai Prompetchara, Sivaporn Gatechompol, Chutitorn Ketloy, Arunee Thitithanyanont, Anan Jongkaewwattana, Supranee Buranapraditkun, Sasiwimol Ubolyam, Stephen J. Kerr, Jiratchaya Sophonphan, Tanakorn Apornpong, Wonngarm Kittanamongkolchai, Sarawut Siwamogsatham, Somchai Sriplienchan, Kanitha Patarakul, Tuangtip Theerawit, Pathariya Promsena, Rapisa Nantanee, Siwaporn Manomaisantiphap, Sarun Chokyakorn, Lina Hong, Mijo Samija, David C. Montefiori, Hongmei Gao, Amanda Eaton, Wassana Wijagkanalan, Mohamad-Gabriel Alameh, Drew Weissman, Kiat Ruxrungtham, ChulaVac001-Phase 2 study team
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract ChulaCov19 mRNA vaccine demonstrated promising phase 1 results. Healthy adults aged 18–59 years were double-blind randomised 4:1 to receive two intramuscular doses of ChulaCov19 50 µg or placebo. Primary endpoints were safety and microneu
Externí odkaz:
https://doaj.org/article/54f54eeb03db4688a4ae18fe00c232c3
Autor:
Napaporn Chantasrisawad, Chonnamet Techasaensiri, Pope Kosalaraksa, Wanatpreeya Phongsamart, Auchara Tangsathapornpong, Peera Jaru-Ampornpan, Jiratchaya Sophonphan, Piyarat Suntarattiwong, Thanyawee Puthanakit
Publikováno v:
International Journal of Infectious Diseases, Vol 130, Iss , Pp 52-59 (2023)
Objectives: To evaluate the immunogenicity of an extended interval regimen of BNT162b2 among healthy school-age children. Methods: A randomized-control trial conducted among healthy Thai children aged 5-11 years. Participants received two doses of BN
Externí odkaz:
https://doaj.org/article/8ebf0f2871fb4731a819ded3fdb0de0e
Autor:
Kanchanok Saraban, Piyarat Suntarattiwong, Napaporn Chantasrisawad, Sophida Boonsathorn, Pope Kosalaraksa, Wanatpreeya Phongsamart, Auchara Tangsathapornpong, Peera Jaruampornpan, Suchada Srisarang, Thanyawee Puthanakit
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100414- (2023)
Objective: To compare the immune response of hybrid immunity – arising from SARS-CoV-2 infection and mRNA BNT162b2 vaccination – to that of 2-doses of vaccine. Methods: In a subanalysis of BNT162b2 vaccine trial in 5 to 11-year-old children, Ther
Externí odkaz:
https://doaj.org/article/1787c343a98041f499cbf437a0b8d7de
Autor:
Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, Orawan Himananto, Supawan Papakhee, Jiratchaya Sophonphan, Monta Tawan, Thidarat Jupimai, Suvaporn Anugulruengkitt, Thanyawee Puthanakit
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100367- (2023)
Background: Children 6 months to 6 months(N = 40) prior to vaccination. Participants in Group A and B received 2-dose BNT162b2 intramuscularly 1 month apart. COVID-naïve children were enrolled as a control group (N = 40) and received 3-dose BNT162b2
Externí odkaz:
https://doaj.org/article/e7758f8b1d364083a4e4eb9a283f7825
Publikováno v:
AJAR (Asian Journal of Accounting Research), Vol 8, Iss 2, Pp 122-132 (2023)
Purpose – Recent research finds that the effect of corporate social responsibility (CSR) information, especially when CSR is not related to core business activities (immaterial CSR issues), on investment decisions will be eliminated when it is expl
Externí odkaz:
https://doaj.org/article/27dd9adfe95f441cacb84a464080627b
Autor:
Sita Lujintanon, Sorawit Amatavete, Supanat Thitipatarakorn, Thanyawee Puthanakit, Wipaporn Natalie Songtaweesin, Tanachai Chaisalee, Surang Janyam, Nittaya Phanuphak, Reshmie A. Ramautarsing
Publikováno v:
Implementation Science Communications, Vol 3, Iss 1, Pp 1-13 (2022)
Abstract Background Same-day antiretroviral therapy (SDART) initiation, in which people living with HIV (PLHIV) who are antiretroviral therapy (ART)-naïve, willing, and clinically eligible start ART on the same day of HIV diagnosis, has been impleme
Externí odkaz:
https://doaj.org/article/c28b6f79735840b796ffab2754166702
Autor:
Watsamon Jantarabenjakul, Piyarat Suntarattiwong, Noppadol Wacharachaisurapol, Praon Supradish Na Ayudhya, Weeraya Phaisal, Monta Tawan, Juthamanee Moonwong, Tavitiya Sudjaritruk, Pajaree Chariyavilaskul, Thanyawee Puthanakit
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 603-608 (2022)
Objectives: To evaluate the pharmacokinetic parameters of the 2020 World Health Organization (WHO)-recommended pediatric dosage of levofloxacin and the higher-than-WHO dosage. Methods: Children aged 1-15 years with tuberculosis who received levofloxa
Externí odkaz:
https://doaj.org/article/8cc1039a735540c7a8e3c50d8323b616
Autor:
Weeraya Phaisal, Watsamon Jantarabenjakul, Noppadol Wacharachaisurapol, Monta Tawan, Thanyawee Puthanakit, Supeecha Wittayalertpanya, Pajaree Chariyavilaskul
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 725-732 (2022)
Objectives: This study investigated the steady-state pharmacokinetic profiles of 3-month weekly rifapentine plus isoniazid (3HP) in children with latent tuberculosisinfection (LTBI). We also assessed other factors, including tablet integrity, food, a
Externí odkaz:
https://doaj.org/article/9d37e177caa5432bb9a17702d29355ba
Autor:
Sirinya Teeraananchai, Stephen J. Kerr, Kiat Ruxrungtham, Panthep Khananuraksa, Thanyawee Puthanakit
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 3, Pp n/a-n/a (2023)
Introduction The Thai National AIDS programme (NAP) treatment guidelines have recommended rapid antiretroviral therapy (ART) initiation, regardless of CD4 count since 2014. We assessed treatment outcomes among youth living with HIV (YLHIV), initiatin
Externí odkaz:
https://doaj.org/article/9a4ef91ca051409db579c5570b19e97d